middle.news
How LTR Pharma’s A$1m Bet on LevOmega Could Reshape Omega-3 Supply
8:45am on Monday 6th of October, 2025 AEDT
•
Pharmaceuticals
Read Story
How LTR Pharma’s A$1m Bet on LevOmega Could Reshape Omega-3 Supply
8:45am on Monday 6th of October, 2025 AEDT
Key Points
Ownership in LevOmega rises from 33% to ~43%
A$1 million invested via LTR Spectrum subsidiary
Supports development of sustainable omega-3 ingredients
Addresses global supply constraints from overfishing and pollution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ltr Pharma (ASX:LTP)
OPEN ARTICLE